T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Vishay Intertechnology
VSH
$5.11B
| $942K | ﹤0.01% |
65,355
+783
| +1% | +$14.8K |
|
|
VISN
1727
Vistance Networks Inc
VISN
$2.62B
| $940K | ﹤0.01% |
103,211
+1,273
| +1% | +$14.8K |
|
1728
Dick's Sporting Goods
DKS
$18.1B
| $937K | ﹤0.01% |
44,070
-5,898
| -12% | -$226K |
|
1729
Universal Corp
UVV
$1.12B
| $934K | ﹤0.01% |
21,127
+2,038
| +11% | +$102K |
|
|
EGRX
1730
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $931K | ﹤0.01% |
20,236
+4,464
| +28% | +$224K |
|
1731
Howard Hughes
HHH
$4.04B
| $928K | ﹤0.01% |
19,275
-17,998
| -48% | -$1.8M |
|
|
MCHB
1732
Mechanics Bancorp
MCHB
$3.79B
| $926K | ﹤0.01% |
41,638
+120
| +0.3% | +$3.47K |
|
1733
InterDigital
IDCC
$8.88B
| $924K | ﹤0.01% |
20,707
+196
| +1% | +$10.3K |
|
1734
Associated Banc-Corp
ASB
$6.07B
| $920K | ﹤0.01% |
71,905
-122
| -0.2% | -$2.19K |
|
1735
Cohu
COHU
$2.76B
| $920K | ﹤0.01% |
74,275
-1,961
| -3% | -$40K |
|
1736
The GEO Group
GEO
$4B
| $916K | ﹤0.01% |
75,338
-16,150
| -18% | -$247K |
|
1737
TriNet
TNET
$3.22B
| $915K | ﹤0.01% |
24,299
+1,479
| +6% | +$77K |
|
1738
NetEase
NTES
$78.5B
| $913K | ﹤0.01% |
14,220
-549,605
| -97% | -$36.1M |
|
1739
United Fire Group
UFCS
$1.38B
| $912K | ﹤0.01% |
27,958
-1,379
| -5% | -$56K |
|
1740
Kforce
KFRC
$1.08B
| $911K | ﹤0.01% |
35,614
+13,421
| +60% | +$445K |
|
|
CIM
1741
Chimera Investment
CIM
$993M
| $910K | ﹤0.01% |
33,327
+1,560
| +5% | +$88.6K |
|
1742
Cedar Fair
FUN
$1.71B
| $908K | ﹤0.01% |
49,497
-500
| -1% | -$22K |
|
|
EPAY
1743
DELISTED
Bottomline Technologies Inc
EPAY
| $908K | ﹤0.01% |
24,778
+247
| +1% | +$11.4K |
|
1744
Tompkins Financial
TMP
$1.45B
| $897K | ﹤0.01% |
12,490
+2,271
| +22% | +$188K |
|
|
FTSV
1745
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $896K | ﹤0.01% |
9,395
-893,430
| -99% | -$54M |
|
1746
Manulife Financial
MFC
$72.9B
| $894K | ﹤0.01% |
71,987
+3,165
| +5% | +$55K |
|
|
BHVN
1747
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $893K | ﹤0.01% |
26,238
+462
| +2% | +$21.1K |
|
1748
Ares Management
ARES
$33.7B
| $891K | ﹤0.01% |
+28,818
| New | +$1.01M |
|
|
AVTA
1749
DELISTED
Avantax, Inc. Common Stock
AVTA
| $888K | ﹤0.01% |
73,679
+14,210
| +24% | +$274K |
|
1750
BlackLine
BL
$1.82B
| $887K | ﹤0.01% |
16,860
+259
| +2% | +$15.1K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.